17 results · 35ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LITHIUM REGENT MODEL TR66056 / LITHIUM STANDARD TR66901

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

Henry Schein

FDA UDI
HENRY SCHEIN, INC.·00304040045060·Scaler Crane Kaplan DE #6

KALORE™

FDA UDI
Gc America Inc.·14548161293174·KALORE™ Syringes (2 mL/4 g) B2

KALORE™

FDA UDI
Gc America Inc.·D0470035831·KALORE™ Syringes (2 mL/4 g) B2

FASTTAKE COMPACT BLOOD GLUCOSE MONITORING SYSTEM

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

ISLAND BIOSURGICAL BNS KIT #3

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

INFINION CX

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·July 13, 2023

WAVEWRITER ALPHA?

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION CORPORATION·Product code LGW·December 16, 2025

M SERIES

FDA Adverse Event
Malfunction ·ZOLL MEDICAL CORPORATION·Product code MKJ·February 7, 2013

PRECISION

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·February 22, 2011

INFINITI VISION SYSTEM

FDA Adverse Event
Death ·ALCON - IRVINE TECHNOLOGY CENTER·Product code HQC·February 20, 2008

TRUSTEEL

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·June 26, 2024

TRUSTEEL

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·June 26, 2024

TRUSTEEL

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·June 26, 2024

smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

Ultrasound System 1300, bkSpecto w/battery; Model No. 1300-21 or 1300-S1; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024